U.S. Population Health Management Market Size to Hit Around USD 158.63 Bn By 2032
The U.S. Population Health Management market size was exhibited at USD 26.60 billion in 2022 and is projected to hit around USD 158.63 billion by 2032, growing at a CAGR of 19.55% during the forecast period 2023 to 2032.
Key Takeaways:
U.S. Population Health Management Market Report Scope
| Report Attribute | Details |
| Market Size in 2023 | USD 31.8 Billion |
| Market Size by 2032 | USD 158.63 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 19.55% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, End use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Allscripts Healthcare; Cerner Corp.; Conifer Health Solutions, LLC; EClinicalWorks; Enli Health Intelligence; McKesson Corp.; Medecision; Optum, Inc.; Advisory Board; Koninklijke Philips N.V.; Athenahealth, Inc.; RedBrick Health; Welltok |
The Increase in healthcare expenditure, need for value-based healthcare delivery, and effective disease management across different care settings are among the key factors expected to drive the market during the forecast period.
In the U.S., poor healthcare management results in the loss of productivity and a significant portion of healthcare costs. Adoption of PHM software by employers helps in the management of their healthcare budget as they can keep a track of the employees’ health status. The market is likely to witness rapid growth in the coming years due to the growing demand for healthcare IT services and solutions that encourage healthcare delivery reliant on value, resulting in a transition from Fee-For-Service to a value-based payment model.
Population health management is built on a Fee-for-Service (FFS) reimbursement method, wherein physicians and other healthcare providers are reimbursed by government agencies and insurance companies on basis of the number of services offered to patients. The new payment model allows reimbursement based on the quality of care delivered and provides comprehensive tools to handle financial and clinical risk for value-based care delivery.
The COVID-19 pandemic has changed the outlook of healthcare in the U.S. with the advanced use of web-based technology in healthcare. Healthcare providers are increasingly investing in PHM software to offer better outcomes. PHM can also be used for tracking the vital signs of patients discharged from hospitals, which can then be analyzed to offer meaningful insights into a patient’s health. The lockdown has disrupted the existing system and PHM systems are the current need to manage the patient population.
Product Insights
The services segment dominated the market in 2022 with a revenue share of more than 52.36% owing to the high demand for post-purchase assistance for PHM solutions. On the other hand, the software segment is expected to register the fastest CAGR of 19.73% over the forecast years. The growth is credited to the well-managed network of software that provides actionable analytics for providers and the ability to manage multiple lines of business seamlessly on one platform.
PHM programs can process clinical, financial, and operational data to improve efficiency and patient care. Healthcare systems use healthcare Customer-Relationship Management (CRM) platforms to organize and analyze large volumes of data and derive consumer insights. These can be used to inform PHM campaigns, leading to personalized patient engagement and improved health outcomes. In May 2020, Allscripts Healthcare, LLC launched CarePort Connect, a new post-discharge tool. The tool is designed to assist hospitals in complying with the interoperability final rules of the Centers for Medicare and Medicaid Services.
The services segment currently holds more than 50% of the market share, as an in-house system is typically preferred over third-party providers for the assessment of patient data by hospitals and other healthcare providers. The Patient-Centered Medical Home (PCMH), a holistic approach to primary care designed to improve care coordination, is among the key building blocks of PHM. PCMHs can track patients’ health conditions systematically & reach out to those who do not visit their doctors regularly to address poor health behavior.
End Use Insights
Based on end use, the market is segmented into providers, payers, and employer groups, out of which, providers held a majority of the market share of over 49.16% in 2022. Healthcare providers need PHM systems that are compatible with Electronic Health Record (EHR) systems to assist in delivering holistic, patient-centric care. Multiple functionalities and advantages offered by PHM solutions are responsible for their increased adoption. The Centers for Medicare & Medicaid Services has announced that the Alternative Payment Model and the Merit-Based Incentive Payment System will help these providers develop technical management capabilities.
Payers in healthcare are third-party entities, such as insurance carriers. The cost of health services is financed or reimbursed by these entities. Predictive analytics competency provides payers an opportunity to leverage over other providers in the interpretation of unstructured clinical content and population behavior. This competitive advantage is efficient to increase the demand for PHM software for payers.
Employer groups require consumer-focused health plans to ensure the well-being of employees. Employee satisfaction is the most important metric as it ensures better services from employees. Employer groups as end users are evolving into a significant market for PHM as it helps employers in information management as well as financial risk management. The employer group end use segment is expected to emerge as the fastest-growing segment with a CAGR of 21.24% during the forecast period. owing to the rising demand for identifying the health and wellness needs of the employee population, which is very essential for a successful business.
Key Companies & Market Share Insights
The market players are increasing their interactions with healthcare systems and organizations leading to multi-level networking within the healthcare industry. The key players are undertaking strategic activities including research initiatives, launching new products, regional expansion, partnerships & collaborations, and mergers & acquisitions to gain a competitive advantage. For Instance, In May 2020, Medecision announced a few important enhancements to its Aerial Platform, to enable customers to support vulnerable patients and members during the COVID-19 crisis. Some of the key players in the U.S. population health management market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Population Health Management market.
By Product
By End-use
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Nova One Advisor’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Research Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
1.9.3 Objective - 3
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 End Use
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Growing demand for value-based healthcare delivery
3.1.1.2 Rising healthcare expenditure
3.1.1.3 Need for effective disease management across different care settings
3.1.1.4 Rapidly aging population in the U.S.
3.1.2 Market Restraint Analysis
3.1.2.1 Lack of proper regulatory framework for PHM
3.1.2.2 High cost and challenges related to treatment model
3.2 U.S. Population Health Management (PHM) Market: Business Environment Analysis Tools
3.2.1 Porter’s Five Forces Analysis
3.2.1.1 Threat of new entrants: Moderate to High
3.2.1.2 Threat of substitutes: High
3.2.1.3 Competitive rivalry: High
3.2.1.4 Bargaining power of suppliers: High
3.2.1.5 Bargaining power of buyers: Low
3.2.2 PESTEL Analysis
3.2.2.1 Political & Legal
3.2.2.2 Economic
3.2.2.3 Technological
3.3 Penetration & Growth Prospect Mapping
3.4 Regulatory Scenario & Reimbursement Framework
3.5 COVID-19 Pandemic Impact: Qualitative Analysis
Chapter 4 U.S. Population Health Management (PHM) Market: Product Analysis
4.1 U.S. Population Health Management (PHM) Product Market Share Analysis, 2023 & 2032
4.2 U.S. Population Health Management (PHM) Market: Product Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the Product Segment
4.3.1 Software
4.3.1.1 Software market, 2020 - 2032
4.3.2 Services
4.3.2.1 Services market, 2020 - 2032
Chapter 5 U.S. Population Health Management (PHM) Market: End Use Analysis
5.1 U.S. Population Health Management (PHM) End Use Market Share Analysis, 2023 & 2032
5.2 U.S. Population Health Management (PHM) Market: End Use Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the End Use Segment
5.3.1 Providers
5.3.1.1 Providers market, 2020 - 2032
5.3.2 Payers
5.3.2.1 Payers market, 2020 - 2032
5.3.3 Employer Groups
5.3.3.1 Employer Groups market, 2020 - 2032
Chapter 6 Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Company/Competition Categorization
6.3 Company Market Position Analysis
6.4 List of Few PHM Vendors in the U.S.
6.5 Company Profiles
6.5.1 ALLSCRIPTS HEALTHCARE, LLC
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 CERNER Corporation
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 CONIFER HEALTH SOLUTIONS, LLC
6.5.3.1 Company overview
6.5.3.2 Financial performance
6.5.3.3 Product benchmarking
6.5.3.4 Strategic initiatives
6.5.4 ECLINICALWORKS
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 Cedar Gate Technologies
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 MCKESSON CORPORATION
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 MEDECISION
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
6.5.8 OPTUM, INC.
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.9 ADVISORY BOARD
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Strategic initiatives
6.5.10 KONINKLIJKE PHILIPS N.V.
6.5.10.1 Company overview
6.5.10.2 Financial performance
6.5.10.3 Product benchmarking
6.5.10.4 Strategic initiatives
6.5.11 ATHENAHEALTH, INC.
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 REDBRICK HEALTH CORPORATION
6.5.12.1 Company overview
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking
6.5.12.4 Strategic initiatives
6.5.13 WELLTOK
6.5.13.1 Company overview
6.5.13.2 Financial performance
6.5.13.3 Product benchmarking
6.5.13.4 Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers